Aurinia Pharmaceuticals ($AUPH) Insider Trading & Smart Money Activity

Aurinia Pharmaceuticals Inc. · Biotechnology · Latest filing May 15, 2026

Aurinia Pharmaceuticals Inc. ($AUPH) has 4 13F position changes on file.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 4
Analyst ratings on file: 0

AUPH insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	2 / 2
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All AUPH insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	1W	1M	Story
May 15, 2026	13F	Two Sigma Investments	Added	+1.47M sh	$58.19M	-0.4%	+4.7%	Read
May 15, 2026	13F	Two Sigma Advisers	Sold out	-1.31M sh		-0.4%	+4.7%	—
May 15, 2026	13F	Two Sigma Advisers	Sold out	-1.31M sh		-0.4%	+4.7%	—
May 11, 2026	13F	Walleye Capital	Added	+298.66K sh	$5.46M	-0.8%	-0.4%	—

1W / 1M / 6M = how AUPH moved from the trade or filing date.

Institutions moving AUPH (13F)

Frequently asked questions

Which institutions changed their AUPH positions?

Recent 13F filers moving the stock include Two Sigma Advisers, Two Sigma Investments and Walleye Capital.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text